UK - Pension funds want drugs giant GlaxoSmithKline to explain why its chief executive's pay package is rising by £2.5m while the firm's share price is falling sharply.
The National Association of Pension Funds’ request follows a letter from the company stating its intention to recommend an increase in Jean-Pierre Garnier’s “long-term incentive grants”. The let...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date